Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma

Blood Cancer J. 2016 Nov 11;6(11):e500. doi: 10.1038/bcj.2016.108.

Authors

E Spanoudakis¹, M Papoutselis¹, E Terpos², M A Dimopoulos², C Tsatalas¹, D Margaritis¹, A Rahemtulla³, I Kotsianidis¹, A Karadimitris³

Affiliations

¹ Department of Haematology, Democritus University of Thrace, Alexandroupolis, Greece.
² Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece.
³ Centre for Haematology, Department of Medicine, Hammersmith Hospital, Imperial College London, London, UK.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Bone Marrow / immunology
Bone Marrow / metabolism*
Bone Marrow / pathology
Bone Marrow Cells / metabolism
Bone Marrow Cells / pathology
Female
Gene Expression Regulation, Neoplastic
Humans
Male
Middle Aged
Multiple Myeloma / genetics*
Multiple Myeloma / immunology
Multiple Myeloma / metabolism
Multiple Myeloma / pathology
Natural Killer T-Cells / metabolism*
Natural Killer T-Cells / pathology
RANK Ligand / genetics*
Up-Regulation / genetics

Substances

RANK Ligand
TNFSF11 protein, human